4.8 Article

Tandem Mass Spectrometric Quantification of 93 Terpenoids in Cannabis Using Static Headspace Injections

Journal

ANALYTICAL CHEMISTRY
Volume 91, Issue 17, Pages 11425-11432

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.9b02844

Keywords

-

Funding

  1. Evelyn Gruss Lipper Charitable Foundation
  2. Israeli Ministry of Agriculture and Rural Development
  3. Technion by Lady Davis Foundation
  4. Levi Eshkol fellowship of the Israel Ministry of Science

Ask authors/readers for more resources

The therapeutic effect of Cannabis largely depends on the content of its pharmacologically active secondary metabolites, mainly phytocannabinoids, flavonoids, and terpenoids. Recent studies suggest there are therapeutic effects of specific terpenoids as well as synergistic effects with other active compounds in the plant. Although Cannabis contains an overwhelming milieu of terpenoids, only a limited number are currently reported and used for metabolic analysis of Cannabis chemovars. In this study, we report the development and validation of a method for simultaneous quantification of 93 terpenoids in Cannabis air-dried inflorescences and extracts. This method employs the full evaporation technique via a static headspace sampler, followed by gas chromatography-mass spectrometry (SHS-GC/MS/MS). In the validation process, spiked terpenoids were quantified with acceptable repeatability, reproducibility, sensitivity, and accuracy. Three medical Cannabis chemovars were used to study the effect of sample preparation and extraction methods on terpenoid profiles. This method was further applied for studying the terpenoid profiles of 16 different chemovars acquired at different dates. Our results demonstrate that sample preparation methods may significantly impact the chemical fingerprint compared to the nontreated Cannabis. This emphasizes the importance of performing SHS extraction in order to study the natural terpenoid contents of chemovars. We also concluded that most inflorescences expressed relatively unique terpenoid profiles for the most pronounced terpenoids, even when sampled at different dates, although absolute concentrations may vary due to aging. The suggested method offers an ideal tool for terpenoid profiling of Cannabis and sets the scene for more comprehensive works in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Anesthesiology

Sex differences in medical cannabis-related adverse effects

Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Paula Berman, Anna Shapira, Shiri Procaccia, David Meiri

Summary: Studies have shown that women are more susceptible to adverse effects from conventional drugs. This study aimed to investigate the differences of medical cannabis-related adverse effects between women and men in patients with chronic noncancer pain. The results showed that women reported more medical cannabis-related adverse effects, possibly due to both the inherent sex effect and the consumption of specific phytocannabinoid compositions.
Article Biophysics

Bioelectricity generation from live marine photosynthetic macroalgae

Yaniv Shlosberg, Nimrod Krupnik, Tunde N. Toth, Ben Eichenbaum, Matan M. Meirovich, David Meiri, Omer Yehezkeli, Gadi Schuster, Alvaro Israel, Noam Adir

Summary: The study demonstrates the potential of using intact live marine macroalgae in BPECs to produce high electrical currents. These currents are significantly greater than those reported for single-cell microorganisms, indicating a promising approach for low-cost solar energy conversion technologies.

BIOSENSORS & BIOELECTRONICS (2022)

Review Pharmacology & Pharmacy

Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

Shiri Procaccia, Gil Moshe Lewitus, Carni Lipson Feder, Anna Shapira, Paula Berman, David Meiri

Summary: Medical cannabis and its major components THC and CBD are gaining popularity for various medical purposes, but studies regarding their efficacy are inconclusive due to the versatile nature of the cannabis plant and the interplay between its compounds and the endocannabinoid system.

FRONTIERS IN PHARMACOLOGY (2022)

Correction Oncology

Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. (vol 12, 2447, 2020)

Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, Gil M. Lewitus, Lanuel Oz-Ari, Ayellet Jehassi, Avivit Peer, Ilit Turgeman, Olga Vernicova, Paula Berman, Mira Wollner, Mor Moskovitz, David Meiri

CANCERS (2022)

Article Biochemistry & Molecular Biology

Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model

Zhanna Yekhtin, Iman Khuja, David Meiri, Reuven Or, Osnat Almogi-Hazan

Summary: Phytocannabinoids have immune regulatory properties that can modulate macrophage function through the endocannabinoid system. In this study, the effects of specific phytocannabinoids on macrophage activation were evaluated. The results showed that phytocannabinoids inhibited macrophage activation, reduced inflammation in a murine model of colitis, and had unique effects on cytokine composition. Understanding the relationship between cannabinoids and immunity is crucial for developing targeted treatment strategies.

BIOMEDICINES (2022)

Article Pharmacology & Pharmacy

Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety

Orit Stolar, Ariela Hazan, Roni Enten Vissoker, Ibrahim Abu Kishk, Dana Barchel, Mirit Lezinger, Adi Dagan, Nir Treves, David Meiri, Matitiahu Berkovitch, Elkana Kohn, Eli Heyman

Summary: This study aimed to assess the safety of CBD-rich oil treatment in children and adolescents with ASD. The results of analyzing data from 59 participants showed that CBD-rich cannabis oil had a good safety profile and did not cause significant side effects in the short term. However, further long-term monitoring with a larger number of participants is needed.

FRONTIERS IN PHARMACOLOGY (2022)

Article Oncology

The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief?

Barliz Waissengrin, Yasmin Leshem, Marwa Taya, David Meiri, Ofer Merimsky, Sivan Shamai, Ido Wolf, Tami Rubinek

Summary: This study aimed to evaluate the effect of cannabis on the efficiency of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) patients. The results from both preclinical and clinical observations showed that cannabis does not reduce the effectiveness of ICIs. Although cannabis users were younger and more likely to have symptoms such as brain metastasis, there was no correlation between cannabis use and overall survival. These findings provide reassurance that cannabis does not have a deleterious effect on treatment outcomes in this clinical setting.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma and the Quest for Cannabis-Based Personalized Therapy

Kifah Blal, Elazar Besser, Shiri Procaccia, Ouri Schwob, Yaniv Lerenthal, Jawad Abu Tair, David Meiri, Ofra Benny

Summary: The survival rate of head and neck cancer has only improved slightly over the last 25 years, highlighting the need for new treatment options. This research found that decarboxylated CBD-rich extracts had the strongest anti-tumor effects on head and neck cancer cells, and combining CBD with CBC in a 2:1 ratio enhanced the effect. These findings can help in developing better treatment options for head and neck cancer patients.

CANCERS (2023)

Article Psychology, Clinical

Posttraumatic stress disorder, sleep and medical cannabis treatment: A daily diary study

Sharon R. Sznitman, David Meiri, Ben H. Amit, Dennis Rosenberg, Talya Greene

Summary: This study examines the relationship between the use of Medical Cannabis (MC) and sleep disturbances in posttraumatic stress disorder (PTSD) patients. The results show that a shorter time gap between MC use and sleep onset is associated with a lower likelihood of experiencing nightmares throughout the night. However, it is not associated with nightly awakenings or waking up too early. Individuals who used MC products with higher CBD concentrations reported fewer early awakenings.

JOURNAL OF ANXIETY DISORDERS (2022)

Letter Oncology

Antitumoral effects of cannabis in Notch1-mutated T-cell acute lymphoblastic leukemia

Elazar Besser, Anat Gelfand, Gil Moshe Lewitus, Hila Novak-Kotzer, Shiri Procaccia, Paula Berman, Igal Louria-Hayon, Inbar Shreiber-Livne, Yishai Ofran, David Meiri

CANCER COMMUNICATIONS (2023)

Article Plant Sciences

Parallel evolution of cannabinoid biosynthesis

Paula Berman, Luis Alejandro de Haro, Adam Jozwiak, Sayantan Panda, Zoe Pinkas, Younghui Dong, Jelena Cveticanin, Ranjit Barbole, Rotem Livne, Tali Scherf, Eyal Shimoni, Smadar Levin-Zaidman, Nili Dezorella, Ekaterina Petrovich-Kopitman, Sagit Meir, Ilana Rogachev, Prashant D. Sonawane, Asaph Aharoni

Summary: This study uncovers a pathway for cannabinoid production in Helichrysum umbraculigerum, a plant that is genetically distinct from Cannabis. This provides a potential source of new cannabinoids and tools for metabolic engineering.

NATURE PLANTS (2023)

Article Pharmacology & Pharmacy

Solid-State Microwave Drying for Medical Cannabis Inflorescences: A Rapid and Controlled Alternative to Traditional Drying

Almog Uziel, Looz Milay, Shiri Procaccia, Ronen Cohen, Amir Burstein, Liron Sulimani, Inbar Shreiber-Livne, Dan Lewitus, David Meiri

Summary: The article introduces a fast and uniform drying method for Cannabis inflorescences based on solid-state microwave, which can considerably reduce drying time and preserve the composition of secondary metabolites. A drying temperature of 50 degrees Celsius was found to be the most effective in maintaining the chemical profile of phytocannabinoids and terpenoids.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Immunology

Translational Control by 4E-BP1/2 Suppressor Proteins Regulates Mitochondrial Biosynthesis and Function during CD8+ T Cell Proliferation

Ioannis D. Dimitriou, David Meiri, Yulia Jitkova, Alisha R. Elford, Marianne Koritzinsky, Aaron D. Schimmer, Pamela S. Ohashi, Nahum Sonenberg, Robert Rottapel

Summary: In this study, the researchers found that 4E-BP1/2 proteins play a critical role in the proliferation of mouse CD8(+) T cells and the development of antiviral effector function. They also discovered that the translation of genes related to mitochondrial biogenesis is impaired in T cells derived from 4E-BP1/2-deficient mice.

JOURNAL OF IMMUNOLOGY (2022)

Article Clinical Neurology

The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients

Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Gil Bar-Sela, David Meiri

Summary: The use of medical cannabis to treat cancer-related symptoms is increasing. This study prospectively followed up on the effectiveness and safety of medical cannabis treatment in oncology patients. The results showed that most patients experienced significant improvement in symptoms during medical cannabis treatment, with common but non-serious adverse effects.

FRONTIERS IN PAIN RESEARCH (2022)

No Data Available